Mark Cartwright, DVM, Ph.D.
Mark Cartwright is a toxicologic pathologist with over thirty years of biologic and small molecule experience in the biotech and pharmaceutical industry. His experience includes all phases of discovery, nonclinical, and clinical development. Mark contributed to multiple successful drug discovery programs during his career at Merck and Schering Plough, resulting in 23 approved drugs. More recently, Mark was Vice President of Drug Safety and Toxicology for Achillion with responsibility for leadership and decision-making for drug safety across the portfolio. Mark earned his DVM degree from Louisiana State University and his PhD in Comparative and Experiment Pathology from Colorado State University. He is a Fellow of the International Academy of Toxicologic Pathologist and is has authored more than 40 peer-reviewed publications. Mark currently consults with biotech and pharma clients, providing strategic advice and operational support to guide programs through discovery and development.